Scholars Central

Research articlePublished 3 May 2019

Antibacterial Activity of Aqueous and Methanolic Extracts of Olive (Olea europaea L.) Leaves Collected from Different Regions in Morocco

Authors: Lahdibi Sahraoui H, El Berny H, El Karkour M, Quasmaoui H, Charof R, Mennane Z

Der Pharma Chemica

Volume 9 · Issue 13 · Pages 118–124

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of this work was to investigate the antibacterial activity of Aqueous and Methanolic Extracts of Olive (Olea europaea L.) Leaves Collected from Different Regions in Morocco against 31 bacteria strains: five represent ATCC strains and 26 strains are from nosocomial infections (Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Proteus mirabilis, Morganella morganii, Pseudomonas aeruginosa, Acinetobacter baumanii and Staphylococcus aureus from different origins and phenotypes. These strains were collected from the National Institute of Hygiene (NIH) Rabat-Morocco). The Powder of leaves O. europaea L., was extracted by Soxhlet extraction. The antibacterial activity was determined by agar diffusion method. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) have been determined. The extracts were found to be effective against all the bacterial strains, but they were effective against Gram-positive more than Gram-negative bacteria. The maximum inhibitory zone was noted against multiresistant Staphylococcus aureus (20 mm), imipenem resistant A. baumanii (18 mm), they were also active against Extended-Spectrum Beta-Lactamase-(ESBL): E. coli (1 and 3) and Pseudomonas aeruginosa (1) (16 mm and 14 mm respectively). The MIC observed from the aqueous and methanolic leaf extract is 12.5-50 μg/ml and 1.56-12.5 μg/ml respectively. For All the tested strains, bactericidal activity was observed neither for the aqueous extract nor for the methanolic extract. The results indicate that olive can be used for the treatment of various infections and for the development of new antibacterial agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharma Chemica.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Lahdibi Sahraoui H”
  • BylineArticles whose byline prints “El Berny H”
  • BylineArticles whose byline prints “El Karkour M”
  • BylineArticles whose byline prints “Quasmaoui H”
  • BylineArticles whose byline prints “Charof R”
  • BylineArticles whose byline prints “Mennane Z”